Corporates hit Click in $19m round

Drug developers Sanofi and Hikma both contributed to a funding round for health management app developer Click Therapeutics to bring its total financing to more than $26m.

Corporates see Sense for $18m series…

Household energy monitor developer Sense has expanded its overall funding to almost $39m in a round backed by Schneider Electric and existing investors Shell and iRobot.

CrowdStrike considers 2019 IPO

The endpoint security software producer has hired Goldman Sachs for an initial public offering that would enable Alphabet, Rackspace and Telstra to exit.

Events

GCV Synergize 2018
2nd November 2018
Venture Houston 2018
8th November 2018
GCVI Summit 2019
30th January 2019
Vector successfully angles for $70m series B
Kanematsu-backed microsatellite launch services provider Vector has collected $70m in a series B round that brought its total funding to more than $100m.
Vacasa books into $64m round
Vacasa has added $64m in an Assurant-backed round that will help the holiday property manager pursue further domestic and international expansion.
TP Therapeutics tops series C with $80m
The cancer therapy developer has raised $80m in a mezzanine round that came almost 18 months after its series C, with Lilly Asia Ventures and SR One backing both rounds.
Revolution acquires Warp Drive to accelerate progress
Warp Drive Bio, the genomic medicine developer co-founded by Sanofi, has agreed to an all-share acquisition by Revolution Medicines.
CuraSen lures Johnson & Johnson to series A
Johnson & Johnson Innovation – JJDC was among the investors in CuraSen Therapeutics' $54.5m series A round, which was led by New Leaf Venture Partners.
Microsoft returns to WhiteSource for $35m round
Open-source cybersecurity software provider WhiteSource has raised cash in a series C round led by Susquehanna Growth Equity that included Microsoft's M12 unit.
test reg

Login

Not yet subscribed?

See your subscription offers here